NL-OMON23402Other不适用
Effect of local administration of palivizumab on prevention of RSV infection
适应症
试验速览
- 阶段
- 不适用
- 状态
- Other
- 入组人数
- 348
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Late preterm infants 32-35 weeks gestational age with at least one sibling who are less than 6 months of age at the onset of the RSV season.
排除标准
- •Children with a known cardiac anomaly, Down syndrome or other serious congenital disorders and children who received surfactant treatment are excluded from the study.
研究者
相似试验
撤回
2 期
Effect of intranasal administration of palivizumab on experimental respiratory syncytial viral infection * a human challenge studybronchiolitisNL-OMON55009niversitair Medisch Centrum Utrecht34
进行中（未招募）
1 期
asal administration of palivizumab in an RSV human challenge modelrespiratory syncytial virus infectionEUCTR2020-004137-21-NLniversity Medical Center Utrecht34
招募中
2 期
Effect of intranasal administration of palivizumab on experimental respiratory syncytial viral infection - a controlled human infection studyRSV respiratory tract infection1004743810024970bronchiolitisNL-OMON54420niversitair Medisch Centrum Utrecht34
进行中（未招募）
1 期
asal administration of palivizumab to prevent respiratory syncytial virus infectiorespiratory syncytial virus infectionEUCTR2018-002742-37-NLniversity Medical Center Utrecht408
已完成
2 期
The effect of Bevacizumab on recurrent pterygiaPterygiumpterygium.IRCT201010054856N1Vice Chancellor for research, Baqiyatallah University of Medical Science20